Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||- / 1||- / -|
Administered by: Other Purchased by: ??
Symptoms: Aspiration, Death
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Preexisting Conditions: Medical History/Concurrent Conditions: Asthma; House dust mite allergy
Diagnostic Lab Data:
CDC 'Split Type': DEPFIZER INC2021250304
Write-up: Death; Aspiration; This is a spontaneous report from a non-contactable physician. This is a report received from the regulatory authority-WEB. Regulatory authority or other manufacturer number DE-DCGMA-21188243. A 32-year-old male patient received first dose of BNT162B2 (COMIRNATY, Solution for injection, lot/batch number not provided), via an unspecified route of administration on 12Feb2021(at 32-year-old)at single dose for COVID-19 immunisation. Medical history included: Asthma, House dust mite allergy, both were unknown if ongoing. The patient''s concomitant medications were not reported. 13 hours after vaccination (12Feb2021) the patient developed Aspiration and Death, lasting for unknown. The patient is dead on 12Feb2021. Death cause was reported as Aspiration. An autopsy was performed and results were not provided. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Aspiration
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166